Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$833K Buy
3,312
+305
+10% +$65.6K 0.1% 112
2026
Q1
$654K Buy
3,007
+69
+2% +$15.3K 0.09% 104
2025
Q4
$671K Buy
2,938
+26
+0.9% +$5.92K 0.09% 111
2025
Q3
$674K Sell
2,912
-227
-7% -$46.2K 0.1% 101
2025
Q2
$583K Buy
3,139
+1
+0% +$186 0.09% 105
2025
Q1
$658K Buy
3,138
+10
+0.3% +$1.94K 0.12% 93
2024
Q4
$556K Sell
3,128
-324
-9% -$59.6K 0.12% 85
2024
Q3
$682K Buy
3,452
+14
+0.4% +$2.61K 0.16% 70
2024
Q2
$590K Sell
3,438
-33
-1% -$5.47K 0.15% 59
2024
Q1
$632K Buy
3,471
+134
+4% +$23.1K 0.18% 58
2023
Q4
$517K Sell
3,337
-145
-4% -$21.1K 0.17% 50
2023
Q3
$519K Buy
3,482
+7
+0.2% +$1.03K 0.22% 50
2023
Q2
$468K Buy
3,475
+33
+1% +$4.84K 0.2% 40
2023
Q1
$549K Buy
3,442
+6
+0.2% +$917 0.27% 27
2022
Q4
$555K Buy
+3,436
New +$527K 0.3% 27

Other funds holding ABBV

Unique Wealth's ABBV Position: Q2 2026 in Review

Unique Wealth increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $65.6K and bringing the position to 3,312 shares worth $833K. The position accounts for 0.1% of the portfolio, ranked #112.

Unique Wealth first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Unique Wealth held 3,312 shares of AbbVie worth $833K as of Q2 2026.
  • Unique Wealth bought 305 AbbVie shares in Q2 2026, an estimated $65.6K.
  • AbbVie made up 0.1% of Unique Wealth's portfolio in Q2 2026, its #112 holding.
  • Unique Wealth first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Unique Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.